XML 141 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Changes in Shareholders' Equity - CAD ($)
Common shares
Preferred shares
Additional paid-in capital
Deficit
Accumulated Other Comprehensive Loss
Total
Beginning balance at Dec. 31, 2021     $ 9,214,566 $ (16,609,142) $ (22,316) $ (7,416,892)
Beginning balance (in shares) at Dec. 31, 2021 76,679,908          
Net Income (Loss)       (27,306,350)   (27,306,350)
Share capital issued through private placement     22,388,599     22,388,599
Share capital issued through private placement (in shares) 8,936,167          
Share issue costs     (1,535,727)     (1,535,727)
Cancelled PNRC shares held by NAN     (19,710,608)     (19,710,608)
Cancelled PNRC shares held by NAN (in shares) (7,667,707)          
Cancelled PNRC warrant held by NAN       (28,275,255)   (28,275,255)
PNRC shares exchanged (in shares) (77,948,368)          
PNRC shares received in exchange 82,157,536          
Outstanding shares of NAN acquired on RTO   $ 31,516 87,096,729     87,128,245
Outstanding shares of NAN acquired on RTO (in shares) 31,748,399          
Recapitalization on RTO     (29,174,415)     (29,174,415)
Exercise of warrants     569,399     569,399
Exercise of warrants (in shares) 1,236,408          
Exercise of options     723,076     723,076
Exercise of options (in shares) 1,379,000          
Share-based payment     7,731,117     7,731,117
Exchange differences on translation of foreign operations         (1,178,200) (1,178,200)
Ending balance at Dec. 31, 2022   31,516 77,302,736 (72,190,747) (1,200,516) 3,942,989
Ending balance (in shares) at Dec. 31, 2022 116,521,343          
Net Income (Loss)       (32,376,069)   (32,376,069)
Share capital issued through private placement     39,774,313     39,774,313
Share capital issued through private placement (in shares) 32,342,551          
Share issue costs     (3,058,875)     (3,058,875)
FV of lender warrants     1,744,192     1,744,192
Deferred tax liability on lender warrants     (524,531)     (524,531)
Exercise of warrants     175,000     175,000
Exercise of warrants (in shares) 100,000          
Exercise of options (in shares) 337,026          
Share-based payment     657,138     657,138
Exchange differences on translation of foreign operations         (588,471) (588,471)
Ending balance at Dec. 31, 2023   $ 31,516 $ 116,069,973 $ (104,566,816) $ (1,788,987) $ 9,745,686
Ending balance (in shares) at Dec. 31, 2023 149,300,920